Quimi Daphne — SEC Form 4 filings
SEC reporting owner CIK 1543031. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-16 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 10,000 shares, $17,093 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 5,000 shares @ $1.53 ($7,657) in Century Therapeutics, Inc., filed 2024-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Director | 4 | 2 legs · 5,000 sh · $9,436 | — | 3 |
| Century Therapeutics, Inc. (IPSC) | Director | 4 | 1 leg · 5,000 sh · $7,657 | — | 3 |
Form 4 filings — Quimi Daphne
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 24,372 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | Century Therapeutics, Inc. (IPSC) | Purchase (P): 5,000 @ $1.53 | EDGAR |
| 2024-06-21 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase (P): 2,750 @ $1.89 · Purchase (P): 2,250 @ $1.89 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1543031 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →